ATRC AtriCure Inc

$36.17

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About AtriCure Inc

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally. The company is headquartered in Mason, Ohio.

Website: https://www.atricure.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1323885
Address
7555 INNOVATION WAY, MASON, OH, US
Valuation
Market Cap
$1.58B
P/E Ratio
nan
PEG Ratio
-1.18
Price to Book
3.44
Performance
EPS
$-0.95
Dividend Yield
—
Profit Margin
-9.61%
ROE
-9.64%
Technicals
50D MA
$35.67
200D MA
$31.30
52W High
$43.11
52W Low
$18.94
Fundamentals
Shares Outstanding
49M
Target Price
$52.22
Beta
1.65

ATRC EPS Estimates vs Actual

● Estimated
● Actual

ATRC News & Sentiment

Nov 20, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is AtriCure ( ATRC ) Stock Outpacing Its Medical Peers This Year?
Here is how AtriCure (ATRC) and Cidara Therapeutics (CDTX) have performed compared to their sector so far this year.
Nov 07, 2025 • Zacks Commentary NEUTRAL
AtriCure ( ATRC ) Loses 13.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for AtriCure (ATRC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Nov 04, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is AtriCure ( ATRC ) Outperforming Other Medical Stocks This Year?
Here is how AtriCure (ATRC) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.
Oct 30, 2025 • Motley Fool SOMEWHAT-BULLISH
AtriCure ( ATRC ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, Oct. 29, 2025, at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...
Oct 29, 2025 • Zacks Commentary NEUTRAL
AtriCure ( ATRC ) Reports Q3 Loss, Beats Revenue Estimates
AtriCure (ATRC) delivered earnings and revenue surprises of +90.91% and +2.09%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Aug 06, 2025 • Motley Fool SOMEWHAT-BULLISH
AtriCure ( ATRC ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Tuesday, July 29, 2025, at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...
Sentiment Snapshot

Average Sentiment Score:

0.212
50 articles with scored sentiment

Overall Sentiment:

Bullish

ATRC Reported Earnings

Jul 29, 2025
Jun 30, 2025 (Pre market)
0.15 Surprise
  • Reported EPS: $-0.02
  • Estimate: $-0.17
  • Whisper: —
  • Surprise %: 88.0%
Apr 29, 2025
Mar 31, 2025 (Pre market)
0.08 Surprise
  • Reported EPS: $-0.14
  • Estimate: $-0.22
  • Whisper: —
  • Surprise %: 37.3%
Feb 12, 2025
Dec 31, 2024 (Pre market)
0.07 Surprise
  • Reported EPS: $-0.08
  • Estimate: $-0.15
  • Whisper: —
  • Surprise %: 46.2%
Oct 29, 2024
Sep 30, 2024 (Post market)
0.02 Surprise
  • Reported EPS: $-0.17
  • Estimate: $-0.19
  • Whisper: —
  • Surprise %: 10.5%
Jul 30, 2024
Jun 30, 2024 (Post market)
0.0 Surprise
  • Reported EPS: $-0.17
  • Estimate: $-0.17
  • Whisper: —
  • Surprise %: 0.0%
May 01, 2024
Mar 31, 2024 (Post market)
-0.05 Surprise
  • Reported EPS: $-0.28
  • Estimate: $-0.23
  • Whisper: —
  • Surprise %: -21.7%
Feb 15, 2024
Dec 31, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $-0.21
  • Estimate: $-0.23
  • Whisper: —
  • Surprise %: 8.7%
Nov 01, 2023
Sep 30, 2023 (Post market)
0.11 Surprise
  • Reported EPS: $-0.20
  • Estimate: $-0.31
  • Whisper: —
  • Surprise %: 35.5%
Jul 25, 2023
Jun 30, 2023 (Post market)
0.19 Surprise
  • Reported EPS: $-0.11
  • Estimate: $-0.30
  • Whisper: —
  • Surprise %: 63.3%

Financials